Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | MGLL | Q99685 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | MLNR | O43193 | 1/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.36 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.36 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1468719 | 1.00 | FAAH (0.43) | FAAHMGLLS1PR1NPC1RAB9A | |
| SCHEMBL1467542 | 0.91 | FAAH (0.43) | FAAHMGLLS1PR1NPC1RAB9A | |
| SCHEMBL1468040 | 0.91 | FAAH (0.43) | FAAHMGLLS1PR1NPC1RAB9A | |
| SCHEMBL1468653 | 0.91 | NPC1 (0.41) | MGLLNPC1RAB9APKMPARP1 | |
| SCHEMBL1467554 | 0.85 | FAAH (0.46) | FAAHMGLLS1PR1NPC1RAB9A | |
| SCHEMBL1468089 | 0.85 | FAAH (0.46) | FAAHMGLLS1PR1NPC1RAB9A | |
| SCHEMBL1468193 | 0.82 | CYP4Z1 (0.41) | FAAHNPC1RAB9APKMPARP1 | |
| SCHEMBL1468585 | 0.81 | NPC1 (0.41) | MGLLNPC1RAB9APKMPARP1 | |
| SCHEMBL1468412 | 0.80 | NPC1 (0.42) | FAAHMGLLS1PR1NPC1RAB9A | |
| SCHEMBL1468580 | 0.78 | FAAH (0.46) | FAAHMGLLS1PR1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8722723-B2 | Aromatic amide derivative | RESEARCH FOUNDATION ITSUU LABORATORY (JP) | 2014-05-13 | — | — | US | disclosed |
| US-20110071304-A1 | AROMATIC AMIDE DERIVATIVE | RESEARCH FOUNDATION ITSUU LABORATORY (JP) | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071304-A1 | AROMATIC AMIDE DERIVATIVE | NCOR2, NCOR1, EP300 | FAAH 2385/4885MGLL 3588/4885S1PR1 4662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.